We are live on ! Find out more
HA

Havens Advisors Portfolio holdings

AUM $39.3M
1-Year Est. Return 80.07%
This Fund
S&P 500
This Quarter Est. Return
+34.22%
1 Year Est. Return
+80.07%
3 Year Est. Return
+460.15%
5 Year Est. Return
+1,430.14%
10 Year Est. Return
AUM
$114M
AUM Growth
+$4.13M
Cap. Flow
-$12M
Cap. Flow %
-10.52%
Top 10 Hldgs %
70.46%
Holding
45
New
18
Increased
5
Reduced
4
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 33.43%
2 Industrials 11.76%
3 Technology 11.56%
4 Consumer Discretionary 7.33%
5 Energy 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY.RT
26
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$499K 0.44%
+165,625
New +$431K
JAG
27
DELISTED
Jagged Peak Energy Inc.
JAG
$157K 0.14%
+18,502
New +$135K
TIVO
28
DELISTED
Tivo Inc
TIVO
$93K 0.08%
+11,022
New +$87.1K
PACB icon
29
Pacific Biosciences
PACB
$435M
$43K 0.04%
8,371
-570,129
-99% -$2.9M
AXTA icon
30
Axalta
AXTA
$7.66B
-50,500
Closed -$1.52M
EXAS
31
PUT
DELISTED
Exact Sciences
EXAS
-13,500
Closed -$1.22M
FOXA icon
32
Fox Class A
FOXA
$24.5B
-9,000
Closed -$284K
HPK icon
33
HighPeak Energy
HPK
$903M
-40,000
Closed -$410K
GWR
34
DELISTED
Genesee & Wyoming Inc.
GWR
-51,503
Closed -$5.69M
CRZO
35
DELISTED
Carrizo Oil & Gas Inc
CRZO
-220,000
Closed -$1.89M
ONCE
36
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-81,300
Closed -$7.88M
GHDX
37
DELISTED
Genomic Health, Inc.
GHDX
-28,000
Closed -$1.9M
CVRS
38
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
-340,000
Closed -$1.46M
MDSO
39
DELISTED
Medidata Solutions, Inc.
MDSO
-47,100
Closed -$4.31M
ALDR
40
DELISTED
Alder Biopharmaceuticals
ALDR
-80,000
Closed -$1.51M
VSM
41
DELISTED
Versum Materials, Inc.
VSM
-48,083
Closed -$2.54M
CELG
42
DELISTED
Celgene Corp
CELG
-146,600
Closed -$14.6M
GCI
43
DELISTED
Gannett Co., Inc
GCI
-110,000
Closed -$1.18M

Similar funds

Havens Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Havens Advisors held 45 positions worth $114M, up 3.8% from $110M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Havens Advisors withdrew a net $12M in Q4 2019, closing 14 positions and reducing 4 holdings. Its most notable exit was Celgene Corp, an estimated $14.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 28% a quarter earlier, followed by Industrials and Technology.

Against the trend, Havens Advisors opened a new position in Wright Medical Group Inc worth $8.77M.

  • Havens Advisors's largest Q4 2019 buy was Wright Medical Group Inc: 287,800 shares worth $8.77M.
  • Havens Advisors added most to WABCO HOLDINGS INC. in Q4 2019, an estimated $2.83M increase.
  • Havens Advisors's biggest Q4 2019 reduction was Mellanox Technologies, Ltd., cutting an estimated $3.12M.
  • Havens Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $14.6M.
  • Havens Advisors's ten largest holdings make up 70% of its $114M portfolio in Q4 2019.
  • Havens Advisors opened 18 new positions and closed 14 in Q4 2019.
  • Havens Advisors's portfolio value rose 3.8% quarter-over-quarter to $114M.

Based on Havens Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.